Skip to main content
Premium Trial:

Request an Annual Quote

Aperiomics Raises $512K in Seed Funding

NEW YORK (GenomeWeb) – Ashburn, Virginia-based Aperiomics today announced that it has closed a seed round of funding, raising $512,000, led by Pipeline Angels, a national network of new and seasoned women angel investors. 

The firm said that by focusing on integrative health providers and private practice physicians, it has grown its customer base more than tenfold during 2017.

Aperiomics said that in a single test, it can identify every known pathogen, including bacteria, viruses, fungi, or parasites. Clinicians and patients call on the company to aid in the identification of infectious diseases that other tests cannot identify or would require a multitude of tests and an idea of what to look for, the firm added.

Through next-generation sequencing of the DNA or RNA in a sample, a complete genetic fingerprint is created and run through a proprietary data analysis algorithm to profile the sample.

Chemical Angel Network also participated in the round.

Aperiomics noted that the National Science Foundation has also been a strong supporter and has provided $1.6 million in grants to the company to date. An additional NSF research grant is expected and will, in part, fund efforts to improve the cost efficiency of the Aperiomics DNA sequencing process, the firm said.  

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.